Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $417.32 million. The enterprise value is $795.62 million.
| Market Cap | 417.32M |
| Enterprise Value | 795.62M |
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 52.10 million shares outstanding. The number of shares has increased by 6.98% in one year.
| Current Share Class | 51.64M |
| Shares Outstanding | 52.10M |
| Shares Change (YoY) | +6.98% |
| Shares Change (QoQ) | -7.26% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 78.66% |
| Float | 46.70M |
Valuation Ratios
The trailing PE ratio is 8.61.
| PE Ratio | 8.61 |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | 1.03 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | 2.66 |
| P/OCF Ratio | 2.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.81, with an EV/FCF ratio of 5.07.
| EV / Earnings | 15.13 |
| EV / Sales | 1.07 |
| EV / EBITDA | 3.81 |
| EV / EBIT | 6.88 |
| EV / FCF | 5.07 |
Financial Position
The company has a current ratio of 5.01, with a Debt / Equity ratio of 1.12.
| Current Ratio | 5.01 |
| Quick Ratio | 2.19 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 2.79 |
| Debt / FCF | 3.72 |
| Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is 10.46% and return on invested capital (ROIC) is 7.69%.
| Return on Equity (ROE) | 10.46% |
| Return on Assets (ROA) | 5.34% |
| Return on Invested Capital (ROIC) | 7.69% |
| Return on Capital Employed (ROCE) | 9.74% |
| Weighted Average Cost of Capital (WACC) | 11.14% |
| Revenue Per Employee | $825,444 |
| Profits Per Employee | $58,444 |
| Employee Count | 900 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, EBS has paid $30.20 million in taxes.
| Income Tax | 30.20M |
| Effective Tax Rate | 36.47% |
Stock Price Statistics
The stock price has increased by +40.04% in the last 52 weeks. The beta is 2.44, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.44 |
| 52-Week Price Change | +40.04% |
| 50-Day Moving Average | 10.25 |
| 200-Day Moving Average | 9.39 |
| Relative Strength Index (RSI) | 31.87 |
| Average Volume (20 Days) | 1,253,208 |
Short Selling Information
The latest short interest is 8.99 million, so 17.25% of the outstanding shares have been sold short.
| Short Interest | 8.99M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 17.25% |
| Short % of Float | 19.24% |
| Short Ratio (days to cover) | 10.92 |
Income Statement
In the last 12 months, EBS had revenue of $742.90 million and earned $52.60 million in profits. Earnings per share was $0.93.
| Revenue | 742.90M |
| Gross Profit | 367.30M |
| Operating Income | 115.60M |
| Pretax Income | 82.80M |
| Net Income | 52.60M |
| EBITDA | 208.90M |
| EBIT | 115.60M |
| Earnings Per Share (EPS) | $0.93 |
Balance Sheet
The company has $205.40 million in cash and $583.70 million in debt, with a net cash position of -$378.30 million or -$7.26 per share.
| Cash & Cash Equivalents | 205.40M |
| Total Debt | 583.70M |
| Net Cash | -378.30M |
| Net Cash Per Share | -$7.26 |
| Equity (Book Value) | 522.60M |
| Book Value Per Share | 10.02 |
| Working Capital | 530.30M |
Cash Flow
In the last 12 months, operating cash flow was $170.60 million and capital expenditures -$13.80 million, giving a free cash flow of $156.80 million.
| Operating Cash Flow | 170.60M |
| Capital Expenditures | -13.80M |
| Depreciation & Amortization | 93.30M |
| Net Borrowing | -112.50M |
| Free Cash Flow | 156.80M |
| FCF Per Share | $3.01 |
Margins
Gross margin is 49.44%, with operating and profit margins of 15.56% and 7.08%.
| Gross Margin | 49.44% |
| Operating Margin | 15.56% |
| Pretax Margin | 11.15% |
| Profit Margin | 7.08% |
| EBITDA Margin | 28.12% |
| EBIT Margin | 15.56% |
| FCF Margin | 21.11% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.98% |
| Shareholder Yield | -6.98% |
| Earnings Yield | 12.60% |
| FCF Yield | 37.57% |
Analyst Forecast
The average price target for EBS is $12.00, which is 49.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 49.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 15.13% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.49 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 7 |